191 related articles for article (PubMed ID: 20529600)
1. [Regulatory T lymphocytes expressing L-selectin in children and adolescents with type 1 diabetes mellitus].
Ryba M; Hak L; Zorena K; Myśliwiec M; Myśliwska J
Pediatr Endocrinol Diabetes Metab; 2010; 16(1):12-6. PubMed ID: 20529600
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cells with CD62L or TNFR2 expression in young type 1 diabetic patients: relation to inflammation, glycemic control and micro-vascular complications.
El-Samahy MH; Adly AA; Ismail EA; Salah NY
J Diabetes Complications; 2015; 29(1):120-6. PubMed ID: 25113439
[TBL] [Abstract][Full Text] [Related]
3. Lower frequency of CD62L(high) and higher frequency of TNFR2(+) Tregs are associated with inflammatory conditions in type 1 diabetic patients.
Ryba M; Rybarczyk-Kapturska K; Zorena K; Myśliwiec M; Myśliwska J
Mediators Inflamm; 2011; 2011():645643. PubMed ID: 21584225
[TBL] [Abstract][Full Text] [Related]
4. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
[TBL] [Abstract][Full Text] [Related]
5. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
[TBL] [Abstract][Full Text] [Related]
6. Anti-TNF rescue CD4+Foxp3+ regulatory T cells in patients with type 1 diabetes from effects mediated by TNF.
Ryba M; Marek N; Hak Ł; Rybarczyk-Kapturska K; Myśliwiec M; Trzonkowski P; Myśliwska J
Cytokine; 2011 Sep; 55(3):353-61. PubMed ID: 21641234
[TBL] [Abstract][Full Text] [Related]
7. Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.
Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2011 May; 41(5):1480-1490. PubMed ID: 21469091
[TBL] [Abstract][Full Text] [Related]
8. The association of the IVS1-397T>C estrogen receptor α polymorphism with the regulatory conditions in longstanding type 1 diabetic girls.
Ryba M; Malinowska E; Rybarczyk-Kapturska K; Brandt A; Myśliwiec M; Myśliwska J
Mol Immunol; 2011 Oct; 49(1-2):324-8. PubMed ID: 21943781
[TBL] [Abstract][Full Text] [Related]
9. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
[TBL] [Abstract][Full Text] [Related]
10. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice.
Lepault F; Gagnerault MC
J Immunol; 2000 Jan; 164(1):240-7. PubMed ID: 10605017
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
12. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
13. High Thymic Output of Effector CD4
Zhao Y; Alard P; Kosiewicz MM
J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853
[TBL] [Abstract][Full Text] [Related]
14. The mRNA expression of pro- and anti-inflammatory cytokines in T regulatory cells in children with type 1 diabetes.
Łuczyński W; Stasiak-Barmuta A; Juchniewicz A; Wawrusiewicz-Kurylonek N; Iłendo E; Kos J; Kretowski A; Górska M; Chyczewski L; Bossowski A
Folia Histochem Cytobiol; 2010 Jan; 48(1):93-100. PubMed ID: 20529823
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation.
Valle A; Barbagiovanni G; Jofra T; Stabilini A; Perol L; Baeyens A; Anand S; Cagnard N; Gagliani N; Piaggio E; Battaglia M
J Immunol; 2015 Mar; 194(5):2117-27. PubMed ID: 25646305
[TBL] [Abstract][Full Text] [Related]
16. [TNF-α, diabetes type 1 and regulatory T cells].
Ryba M; Myśliwska J
Pediatr Endocrinol Diabetes Metab; 2010; 16(4):295-300. PubMed ID: 21447272
[TBL] [Abstract][Full Text] [Related]
17. [Regulatory T cells in children with acute lymphoblastic leukaemia].
Stasiak-Barmuta A; Łuczyński W; Iłendo E; Krawczuk-Rybak M; Szymański M
Med Wieku Rozwoj; 2009; 13(1):53-8. PubMed ID: 19648661
[TBL] [Abstract][Full Text] [Related]
18. [Could the expression of L-selectin be an early marker of arterial hypertension and microangiopathy in the course of type 1 diabetes mellitus in juvenile patients?].
Pawłowski P; Urban M; Peczyńska J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):147-52. PubMed ID: 16232368
[TBL] [Abstract][Full Text] [Related]
19. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
20. [Generation of T regulatory cells in children with type 1 diabetes mellitus].
Luczyński W; Wawrusiewicz-Kurylonek N; Szypowska A; Iłendo E; Bossowski A; Krętowski A; Głowińska-Olszewska B; Hryszko M; Górska M; Stasiak-Barmuta A
Pediatr Endocrinol Diabetes Metab; 2011; 17(2):64-70. PubMed ID: 21722510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
